RecruitingNCT06908980
CHOLE-POSSUM PRO Validation for Prediction of Mortality After Cholecystectomy for Acute Calculous Cholecystitis: Protocol for a Prospective Multicenter Observational Study
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Enrollment
2,500 participants
Start Date
Mar 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
CHOLE-POSSUM PRO is a prospective multicenter observational study on patients with ACC candidate to EC. The rationale of the study is to validate the CHOLE-POSSUM PRO SCORE for 30-day mortality in this population.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
CHOLE-POSSUM PRO is a multicenter observational study for adults 18 and older who have been diagnosed with acute calculous cholecystitis (gallbladder inflammation caused by gallstones) and are undergoing emergency cholecystectomy (gallbladder removal surgery). The study is not testing a new treatment — instead, it aims to validate a scoring tool called the CHOLE-POSSUM PRO score that predicts the risk of death within 30 days after surgery. Eligible patients must meet established diagnostic criteria for acute calculous cholecystitis, be candidates for emergency surgery during their hospital admission, and provide signed informed consent. Participation involves standard clinical care plus the collection of health data needed to test the scoring tool's accuracy. This summary was prepared as patient-facing educational content using AI assistance.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06908980